Go Pro

Weiss Ratings' Rating of Trulieve Cannabis on 6/16/2026

On June 16, 2026, Weiss Ratings updated its outlook on Trulieve Cannabis (NYSE:TRLV) with the action "Initiated Coverage", setting a "Sell (D-)" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Weiss Ratings

DateCompanyAction
5/27/2026
Oak Woods Acquisition Corporation stock logo
OAKU
Oak Woods Acquisition
Reiterated Rating
7/6/2026
Zura Bio Limited stock logo
ZURA
Zura Bio
Reiterated Rating
7/6/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Reiterated Rating
7/6/2026
Wheeler Real Estate Investment Trust, Inc. stock logo
WHLR
Wheeler Real Estate Investment Trust
Reiterated Rating
7/6/2026
Wealthfront stock logo
WLTH
Wealthfront
Reiterated Rating
7/6/2026
Virax Biolabs Group Limited stock logo
VRAX
Virax Biolabs Group
Reiterated Rating
More Ratings From Weiss Ratings